National Cholesterol Education Program Adult Treatment Panel III Versus International Diabetic Federation Definition of Metabolic Syndrome, Which One is Associated with Diabetes Mellitus and Coronary Artery Disease?
- PMID: 22973485
- PMCID: PMC3429802
National Cholesterol Education Program Adult Treatment Panel III Versus International Diabetic Federation Definition of Metabolic Syndrome, Which One is Associated with Diabetes Mellitus and Coronary Artery Disease?
Abstract
Background: A cluster of risk factors for cardiovascular diseases and type 2 diabetes mellitus, which occur together more often than by chance alone, have been known as the metabolic syndrome. Various definitions have been proposed by different organizations over the past decade. This study was designed to evaluate a new definition of the metabolic syndrome for the prediction of diabetes mellitus among the Iranian population.
Methods: This study was carried out in an urban population, aged 20 to 74 years, from Yazd, a city in the center of Iran. The study is a part of the phase I of Yazd Healthy Heart Program, that is, a community-based intervention study for the prevention of cardiovascular disease. The significance level has been defined as P<0.05.
Results: Prevalence of the metabolic syndrome by the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria was 21.3 ± .017%, and by International Diabetes Federation (IDF) criteria it was 30.16 ± .02%. The multivariate analysis showed that the most important relevant factors of diabetes mellitus were: Increased age and metabolic syndrome by both definitions of NCEP and IDF criteria, and also, the most important relevant factors of stable angina were: Increased age, male sex, and metabolic syndrome by only IDF definitions, but the NCEP definition of the metabolic syndrome cannot predict diabetes mellitus independent of age and sex.
Conclusion: This study showed that increased age and metabolic syndrome are the most important relevant factors for diabetes mellitus, especially by using the IDF criteria for definition of the metabolic syndrome.
Keywords: Diabetes mellitus; International diabetes federation; metabolic syndrome.
Conflict of interest statement
Figures
Similar articles
-
The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.Diabetes Care. 2007 May;30(5):1206-11. doi: 10.2337/dc06-1484. Epub 2007 Jan 26. Diabetes Care. 2007. PMID: 17259472
-
Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.Metabolism. 2007 Apr;56(4):552-8. doi: 10.1016/j.metabol.2006.12.003. Metabolism. 2007. PMID: 17379016
-
The reliability of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians.Diabetes Metab Syndr. 2012 Jan-Mar;6(1):4-8. doi: 10.1016/j.dsx.2012.05.017. Epub 2012 Jun 7. Diabetes Metab Syndr. 2012. PMID: 23014247 Clinical Trial.
-
Prognostic interactions between cardiovascular risk factors.Dan Med J. 2014 Jul;61(7):B4892. Dan Med J. 2014. PMID: 25123126 Review.
-
Metabolic syndrome and incident diabetes: current state of the evidence.Diabetes Care. 2008 Sep;31(9):1898-904. doi: 10.2337/dc08-0423. Epub 2008 Jun 30. Diabetes Care. 2008. PMID: 18591398 Free PMC article. Review.
Cited by
-
A Comprehensive Review of Metabolic Syndrome and Its Role in Cardiovascular Disease and Type 2 Diabetes Mellitus: Mechanisms, Risk Factors, and Management.Cureus. 2024 Aug 21;16(8):e67428. doi: 10.7759/cureus.67428. eCollection 2024 Aug. Cureus. 2024. PMID: 39310549 Free PMC article. Review.
-
Insulin Resistance in Type 1 Diabetes Mellitus and Its Association with Patient's Micro- and Macrovascular Complications, Sex Hormones, and Other Clinical Data.Diabetes Ther. 2020 Jan;11(1):161-174. doi: 10.1007/s13300-019-00729-5. Epub 2019 Dec 2. Diabetes Ther. 2020. PMID: 31792784 Free PMC article.
-
Current Data and New Insights into the Genetic Factors of Atherogenic Dyslipidemia Associated with Metabolic Syndrome.Diagnostics (Basel). 2023 Jul 12;13(14):2348. doi: 10.3390/diagnostics13142348. Diagnostics (Basel). 2023. PMID: 37510094 Free PMC article. Review.
-
Nutrition and Lifestyle Behavior Peer Support Program for Adults with Metabolic Syndrome: Outcomes and Lessons Learned from a Feasibility Trial.Nutrients. 2020 Apr 15;12(4):1091. doi: 10.3390/nu12041091. Nutrients. 2020. PMID: 32326541 Free PMC article.
-
The Prevalence of Metabolic Syndrome in Ethiopian Population: A Systematic Review and Meta-analysis.J Obes. 2020 Dec 16;2020:2701309. doi: 10.1155/2020/2701309. eCollection 2020. J Obes. 2020. PMID: 33489358 Free PMC article.
References
-
- Hanley AJ, Karter AJ, Festa A, D’Agostino R, Jr, Wagenknecht LE, Savage P, et al. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study. Diabetes. 2002;51:2642–7. - PubMed
-
- Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415–28. - PubMed
-
- Alwan A, King H, editors. Department of Noncommunicable Disease Surveillance. Geneva: World Health Organization; 1999. World Health Organization: Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus: Report of a WHO consultation; pp. 1–59.
-
- Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA. 2001;285:2486–97. - PubMed
-
- Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab. 2002;28:364–76. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous